| Name | Title | Contact Details |
|---|
At Rebel, we believe that those who contribute make us better. It`s why we create simple, useful tools to empower participation in the world`s bravest communication space: the Internet. We are experts in domain names and the products that make the most of them. This helps our clients showcase their ideas, stories, services and contributions to the world. Our manifesto: be thoughtful, be simple, be brave.
Embolden is an award-winning web development, design and consulting firm.
NexTeks Hosted IT Infrastructure eliminates the need for an in-house server, and instead, moves all that functionality to a state-of-the-art, secure
Glassdoor is one of the largest and fastest growing job sites in the world today. Set apart by the tens of millions of reviews and insights provided by employees and candidates, Glassdoor combines all the jobs with this valuable data to make it easy fo...
Juventas Therapeutics is a private clinical-stage company developing novel therapies for ischemic cardiovascular disease. The company`s lead product` JVS-100` is a non-viral plasmid that encodes for stromal cell-derived factor-1 (SDF-1). SDF-1 has been shown to significantly increase end-organ function following tissue injury by promoting cell survival` recruiting endogenous stem cells to the damaged region` and promoting new blood vessel growth. The SDF-1 repair pathway is well conserved throughout end-organ systems providing the opportunity to impact a broad range of diseases. Target cardiovascular clinical indications address large markets with high unmet medical need and significant market potential. Juventas is currently enrolling multiple clinical trials to test therapy efficacy in heart failure and critical limb ischemia patients.